PAVmed Inc. (PAVM)
NASDAQ: PAVM · IEX Real-Time Price · USD
1.000
-0.010 (-0.99%)
Jul 22, 2024, 9:49 AM EDT - Market open
PAVmed Employees
PAVmed had 107 employees as of December 31, 2023. The number of employees decreased by 17 or -13.71% compared to the previous year.
Employees
107
Change (1Y)
-17
Growth (1Y)
-13.71%
Revenue / Employee
$28,187
Profits / Employee
-$664,047
Market Cap
9.71M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Tonix Pharmaceuticals Holding | 103 |
Pieris Pharmaceuticals | 50 |
Plus Therapeutics | 20 |
ABVC BioPharma | 19 |
Moleculin Biotech | 18 |
Elevai Labs | 18 |
Nexalin Technology | 6 |
Mangoceuticals | 3 |
PAVM News
- 11 days ago - Lucid Diagnostics Launches New Corporate Website - PRNewsWire
- 20 days ago - Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population - PRNewsWire
- 5 weeks ago - PAVmed Subsidiary, Veris Health, Announces Launch of Pilot Program with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute - PRNewsWire
- 5 weeks ago - 4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuard® Esophageal Precancer Testing - PRNewsWire
- 2 months ago - PAVmed Provides Business Update and First Quarter 2024 Financial Results - PRNewsWire
- 2 months ago - Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results - PRNewsWire
- 2 months ago - Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall - PRNewsWire
- 2 months ago - Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of Directors - PRNewsWire